Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.075 USD | -2.96% | -3.09% | -11.15% |
07:10pm | Monte Rosa Therapeutics Prices $100 Million Public Offering | MT |
May. 09 | Monte Rosa Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.15% | 264M | |
+33.52% | 49.46B | |
+1.70% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.81% | 26.61B | |
-22.16% | 18.64B | |
+7.83% | 13.16B | |
+29.52% | 12.55B | |
+24.11% | 12.1B |
- Stock Market
- Equities
- GLUE Stock
- News Monte Rosa Therapeutics, Inc.
- UBS Adjusts Monte Rosa Therapeutics Price Target to $20 From $22, Maintains Buy Rating